Functional studies in non-small cell lung cancer (NSCLC) patients revealed that hyperactivation of the NF-E2-related factor 2 (Nrf2) pathway facilitates tumor growth. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.